Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHPP with Cisplatin + Postop IP Paclitaxel/5-FU for Peritoneal Carcinomatosis
NCT00004547Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Jan 2000
- Primary completion
- Aug 2009
- Modality
- Nanoparticles, Cytokines & Interferons, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Cisplatin micelle injection (HA132), Paclitaxel Micelles for Injection, fluorouracil in peritoneal carcinomatosis (PC), sponsored by National Cancer Institute. Started Jan 2000; status: completed.
02
Drugs
Cisplatin micelle injection (HA132)Paclitaxel Micelles for Injectionfluorouracil
03
Conditions
peritoneal carcinomatosis (PC)
Beyond the preview
Go deeper on NCT00004547.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004547.